| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |